PROLUTEX

This brand name is authorized in Cyprus, Ecuador, Estonia, Spain, Finland, Lithuania, Malta, Poland, Romania, Tunisia, Turkey

Active ingredients

The drug PROLUTEX contains one active pharmaceutical ingredient (API):

1 Progesterone UNII 4G7DS2Q64Y - PROGESTERONE

Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. Read about Progesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DA04	Progesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives
Discover more medicines within G03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 6892-MEE-1221
Country: EE	Ravimiamet	Identifier(s): 1797857
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 78108
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 049910, 059128
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090441
Country: MT	Medicines Authority	Identifier(s): AA1228/01101, AA770/12501
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100302844
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67640001, W67640002, W67640003
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13533031
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680426040136